These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29337643)

  • 1. Models for predicting the evolution of influenza to inform vaccine strain selection.
    Agor JK; Özaltın OY
    Hum Vaccin Immunother; 2018 Mar; 14(3):678-683. PubMed ID: 29337643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza: Can we cope better with the unpredictable?
    Dos Santos G; Neumeier E; Bekkat-Berkani R
    Hum Vaccin Immunother; 2016 Mar; 12(3):699-708. PubMed ID: 26360135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Vaccine Strain Prediction for Human Influenza Viruses.
    Klingen TR; Reimering S; Guzmán CA; McHardy AC
    Trends Microbiol; 2018 Feb; 26(2):119-131. PubMed ID: 29032900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Burden of influenza virus type B and mismatch with the flu vaccine in Spain].
    Eiros-Bouza JM; Pérez-Rubio A
    Rev Esp Quimioter; 2015 Feb; 28(1):39-46. PubMed ID: 25690144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
    Chong Y; Ikematsu H
    Hum Vaccin Immunother; 2018 Mar; 14(3):518-522. PubMed ID: 28857677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: influenza activity--United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(15):325-30. PubMed ID: 9132586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.
    Arencibia A; Piñón A; Acosta B; Fernandez L; Muné M; Valdés O; Savón C; Oropesa S; Gonzalez G; Roque R; Gonzalez G; Hernández B; Alfonso JM
    Infect Genet Evol; 2018 Mar; 58():110-114. PubMed ID: 29229320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of vaccine strains for human influenza A (H3N2) viruses.
    Steinbrück L; Klingen TR; McHardy AC
    J Virol; 2014 Oct; 88(20):12123-32. PubMed ID: 25122778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
    Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
    Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic relationship between influenza A (H3N2) strains circulating in Argentina and vaccine strains].
    Savy VL; Baumeister EG; Pontoriero AV
    Medicina (B Aires); 1999; 59(3):225-30. PubMed ID: 10451559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: influenza activity--United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(18):374-8. PubMed ID: 10369578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: influenza activity--United States and worldwide, 2002-03 season, and composition of the 2003-04 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jun; 52(22):516-21. PubMed ID: 12803198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of influenza B vaccine effectiveness from sequence data.
    Pan Y; Deem MW
    Vaccine; 2016 Aug; 34(38):4610-4617. PubMed ID: 27473305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic distance measurements for seasonal influenza vaccine selection.
    Cai Z; Zhang T; Wan XF
    Vaccine; 2012 Jan; 30(2):448-53. PubMed ID: 22063385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.